Ask AI

Therapeutic Strategies With Selective CDK4/6 Inhibitors: An Oncologist’s Guide to Safe Inhibition of Uncontrolled Cellular Proliferation in Solid Tumors

Review recent developments with selective CDK4/6 inhibitors in the care of patients with various cancers in this text module on-demand Webcast and accompanying slideset developed by Richard Finn MD Geoffrey Shapiro MD PhD and Gary K. Schwartz MD.

Share

Program Content

Supporters

Supported by an educational grant from

Pfizer, Inc.